QRRXQR Rx
    🎗️ OncologyInjection (IV)

    Elahere

    Mirvetuximab Soravtansine

    Folate receptor alpha-directed antibody-drug conjugate for FRα-positive platinum-resistant ovarian cancer.

    Form

    Injection (IV)

    Uses

    1

    Side effects

    5

    Category

    Oncology

    01

    What is Elahere used for?

    • Platinum-resistant ovarian cancer (FRα-positive)
    02

    Mirvetuximab Soravtansine side effects

    Common side effects of Mirvetuximab Soravtansine include:

    Ocular toxicity
    Peripheral neuropathy
    Nausea
    Fatigue
    Diarrhea
    CommonModerateLess common
    03

    Mirvetuximab Soravtansine warnings & precautions

    • Ocular toxicity. Premedication and ophthalmic monitoring required
    • Embryo-fetal toxicity
    • Peripheral neuropathy

    Loading FDA data…

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Elahere in plain language.

    Browse all medications

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.